These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9155659)

  • 1. Transgenic model applications to drug discovery.
    Polites HG
    Int J Exp Pathol; 1996 Dec; 77(6):257-62. PubMed ID: 9155659
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer research forum live discussion: mice on trial? Issues in the design of drug studies.
    J Alzheimers Dis; 2009; 16(1):197-205. PubMed ID: 19158436
    [No Abstract]   [Full Text] [Related]  

  • 3. The program for phenotyping of genetically modified animals at AstraZeneca.
    Berg AL; Bohlooly-Y M
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):383-4. PubMed ID: 16709449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Alzheimer's disease in transgenic mice.
    Duff K
    J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting promising ALS therapies in clinical trials.
    Glass JD; Benatar M; Polak M
    Neurology; 2007 May; 68(18):1545-6; author reply 1546. PubMed ID: 17470765
    [No Abstract]   [Full Text] [Related]  

  • 8. A small molecule targeting the multifactorial nature of Alzheimer's disease.
    Cavalli A; Bolognesi ML; Capsoni S; Andrisano V; Bartolini M; Margotti E; Cattaneo A; Recanatini M; Melchiorre C
    Angew Chem Int Ed Engl; 2007; 46(20):3689-92. PubMed ID: 17397121
    [No Abstract]   [Full Text] [Related]  

  • 9. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease.
    Gil JM; Rego AC
    Brain Res Rev; 2009 Mar; 59(2):410-31. PubMed ID: 19118572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating the mouse that roared.
    Emerson D
    Minn Med; 2001 May; 84(5):6-9. PubMed ID: 11398634
    [No Abstract]   [Full Text] [Related]  

  • 11. Transgenic mouse models of Alzheimer's disease: phenotype and application.
    Higgins GA; Jacobsen H
    Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Animal model for Alzheimer's disease].
    Takashima A; Chui D
    Nihon Rinsho; 2004 Apr; 62 Suppl 4():240-7. PubMed ID: 15174678
    [No Abstract]   [Full Text] [Related]  

  • 13. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Refolo LM; Pappolla MA; LaFrancois J; Malester B; Schmidt SD; Thomas-Bryant T; Tint GS; Wang R; Mercken M; Petanceska SS; Duff KE
    Neurobiol Dis; 2001 Oct; 8(5):890-9. PubMed ID: 11592856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic Alzheimer mice in a semi-naturalistic environment: more plaques, yet not compromised in daily life.
    Lewejohann L; Reefmann N; Widmann P; Ambrée O; Herring A; Keyvani K; Paulus W; Sachser N
    Behav Brain Res; 2009 Jul; 201(1):99-102. PubMed ID: 19428622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A breakthrough for research on Alzheimer disease. A model for drug testing].
    Nordstedt C; Näslund J; Tjernberg LO; Terenius L
    Lakartidningen; 1995 May; 92(18):1899-900. PubMed ID: 7746038
    [No Abstract]   [Full Text] [Related]  

  • 17. [The transgenic mouse model of familial polyposis coli].
    Fehmann HC; Eissele R
    Z Gastroenterol; 1997 Nov; 35(11):1035-7. PubMed ID: 9490555
    [No Abstract]   [Full Text] [Related]  

  • 18. Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.
    Taniguchi T; Doe N; Matsuyama S; Kitamura Y; Mori H; Saito N; Tanaka C
    FEBS Lett; 2005 Oct; 579(25):5704-12. PubMed ID: 16219306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transgenic rats as a model for investigation of the pathogenesis of hypertension].
    Paul M
    Z Kardiol; 1995; 84 Suppl 4():55-60. PubMed ID: 8585274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease.
    Ribes D; Colomina MT; Vicens P; Domingo JL
    Exp Neurol; 2008 Dec; 214(2):293-300. PubMed ID: 18834880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.